EC
NBRV

EcoR1 Capital’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

EcoR1 Capital’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,059
Closed -$2.77M – 48
2017
Q2 		$2.77M Hold
1,059
– – 0.49% 25
2017
Q1 		$3.18M Hold
1,059
– – 0.8% 18
2016
Q4 		$1.58M Sell
1,059
-1,137
-52% -$1.51M 0.5% 23
2016
Q3 		$3.87M Sell
2,196
-55
-2% -$106K 1.19% 24
2016
Q2 		$4.22M Sell
2,251
-580
-20% -$1.17M 1.66% 19
2016
Q1 		$6.34M Sell
2,831
-524
-16% -$1.13M 2.22% 20
2015
Q4 		$7.93M Buy
3,355
+13
+0.4% +$31.7K 2.49% 16
2015
Q3 		$7.94M Buy
+3,342
New +$8.86M 3.61% 11

Other funds holding NBRV

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EcoR1 Capital's NBRV Position: Q3 2017 in Review

EcoR1 Capital sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2017, closing a stake of 1,059 shares — an estimated $2.77M sold.

EcoR1 Capital first reported a position in NBRV in Q3 2015 and held it in 8 quarters. The position peaked at $7.94M in Q3 2015. 41 funds tracked by Wall St. Rank hold NBRV as of Q3 2017.

  • EcoR1 Capital reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2017 after selling out during the quarter.
  • EcoR1 Capital sold 1,059 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2017, an estimated $2.77M.
  • EcoR1 Capital first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 8 quarters.
  • EcoR1 Capital's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $7.94M in Q3 2015.
  • 41 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2017.

Based on EcoR1 Capital's 13F filing for Q3 2017, filed 14 Nov 2017.